Literature DB >> 1789994

Determination of allotypes G1m(f) and G1m(z) at the genomic level by subclass-specific amplification of DNA and use of allele-specific probes.

M Balbín1, A Grubb, M Abrahamson, R Grubb.   

Abstract

Two oligonucleotide primers were used for selective enzymatic amplification of a DNA segment encoding a major portion of the first constant region domain (CH1) of the human IgG1 heavy chain. The selective amplification was confirmed by use of subclass-specific oligonucleotide probes. Two 15-mer oligonucleotides, hybridizing with the alleles for the allotypes G1m(f) and (z), respectively, could then be used for determination at the genomic level of these two truly allelic allotypes. Serum and DNA samples from 12 individuals, one of them with a considerable amount of anti-Gm(f) antibodies, were used for allotype assignment by classical serological methods and by the new method operating at the genomic level. The resulting classifications agreed completely, demonstrating the reliability of the new method.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1789994

Source DB:  PubMed          Journal:  Exp Clin Immunogenet        ISSN: 0254-9670


  13 in total

1.  Immunoglobulin GM and KM genotypes in Korean patients with systemic lupus erythematosus.

Authors:  E B Lee; Y J Lee; D H Shin; Y M Choi; M H Park; J P Pandey; Y W Song
Journal:  Rheumatol Int       Date:  2006-08-31       Impact factor: 2.631

2.  A novel mutation in the beta-protein coding region of the amyloid beta-protein precursor (APP) gene.

Authors:  M Balbín; M Abrahamson; L Gustafson; K Nilsson; A Brun; A Grubb
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

3.  Interaction between immunoglobulin allotypes and NK receptor genes in diabetes post-hepatitis C virus infection.

Authors:  Julio Granados-Montiel; Joaquin Zúñiga; Jose Azocar; Edmond J Feris; Daniel Terreros; Charles E Larsen; Olga P Clavijo; Alfredo Cruz-Lagunas; Derek Middleton; Chester A Alper; Janardan P Pandey; Edmond J Yunis
Journal:  Immunobiology       Date:  2010-11-05       Impact factor: 3.144

4.  The immunoglobulin γ marker 17 allotype and KIR/HLA genes prevent the development of chronic hepatitis B in humans.

Authors:  Danilo Di Bona; Janardan P Pandey; Anna Aiello; Massimo Bilancia; Giuseppina Candore; Calogero Caruso; Claudia Colomba; Giovanni Duro; Mattia Emanuela Ligotti; Luigi Macchia; Sergio Rizzo; Giulia Accardi
Journal:  Immunology       Date:  2019-11-12       Impact factor: 7.397

5.  Molecular characterization of Gm(n+) and G2m(n-) allotypes.

Authors:  A Brusco; G G de Lange; C Boccazzi; A O Carbonara
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

6.  Immunoglobulin allotype gene polymorphisms in systemic sclerosis: interactive effect of MHC class II and KM genes on anticentromere antibody production.

Authors:  H Kameda; J P Pandey; J Kaburaki; H Inoko; M Kuwana
Journal:  Ann Rheum Dis       Date:  1998-06       Impact factor: 19.103

7.  Epistatic interactions between Fc (GM) and FcγR genes and the host control of human immunodeficiency virus replication.

Authors:  Raymond N Deepe; Emily Kistner-Griffin; Jeffrey N Martin; Steven G Deeks; Janardan P Pandey
Journal:  Hum Immunol       Date:  2011-12-11       Impact factor: 2.850

8.  Immunoglobulin genes and the acquisition of HIV infection in a randomized trial of recombinant adenovirus HIV vaccine.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Shizhong Bu; Jean De Dieu Tapsoba; Alicia Sato; James Y Dai
Journal:  Virology       Date:  2013-04-11       Impact factor: 3.616

9.  Genetic markers of IgG influence the outcome of infection with hepatitis C virus.

Authors:  Janardan P Pandey; Aryan M Namboodiri; Yuqun Luo; Yuping Wu; Robert C Elston; David L Thomas; Hugo R Rosen; James J Goedert
Journal:  J Infect Dis       Date:  2008-11-01       Impact factor: 5.226

10.  Interactive effects of immunoglobulin gamma and human leucocyte antigen genotypes on clearance and persistence of infection with hepatitis C virus.

Authors:  J P Pandey; M A Montes-Cano; J Aguilar-Reina; M F Gonzalez-Escribano
Journal:  Clin Exp Immunol       Date:  2007-10-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.